HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.

AuthorsLaia Valls, Christopher Hoimes, Andrew Sher, Lingzhi Hu, Zhenghong Lee, Raymond Muzic, Norbert Avril
JournalSeminars in roentgenology (Semin Roentgenol) Vol. 49 Issue 3 Pg. 238-41 (Jul 2014) ISSN: 1558-4658 [Electronic] United States
PMID25497908 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Contrast Media
  • Indoles
  • Protein Kinase Inhibitors
  • Pyrroles
  • Radiopharmaceuticals
  • (18F)fluoroethyltyrosine
  • Tyrosine
  • Gadolinium DTPA
  • Sunitinib
Topics
  • Antineoplastic Agents (therapeutic use)
  • Carcinoma, Renal Cell (diagnosis, drug therapy, secondary)
  • Contrast Media
  • Diffusion Magnetic Resonance Imaging
  • Gadolinium DTPA
  • Humans
  • Image Enhancement
  • Indoles (therapeutic use)
  • Kidney Neoplasms (diagnosis, drug therapy, secondary)
  • Magnetic Resonance Spectroscopy
  • Male
  • Middle Aged
  • Multimodal Imaging
  • Positron-Emission Tomography
  • Protein Kinase Inhibitors (therapeutic use)
  • Pyrroles (therapeutic use)
  • Radiopharmaceuticals
  • Sunitinib
  • Tomography, X-Ray Computed
  • Treatment Outcome
  • Tyrosine (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: